Early Clinical case studies
Explore our expertise and success stories.
Explore our library of case studies with innovative early clinical solutions that will advance your drug development strategy
ICON is committed to the highest standards of excellence and scientific expertise in early clinical drug development.
Multinational phase 1 biosimilar study
ICON conducted a multinational biosimilar phase 1 study for multiple sclerosis (MS). This trial was performed under high regulatory scrutiny and challenging pandemic conditions, with increased dosing targets requiring additional site activation.
Volunteer recruitment for an early phase hot flash study
ICON assisted in the recruitment of participants for a hot flash study that had a set of complex eligibility requirements.
Success in early phase psoriasis study
A randomised, double-blind, placebo-controlled study on behalf of a biotechnology organisation to evaluate the safety, tolerability, and efficacy of the study drug in subjects with moderate to severe plaque psoriasis.